Mickle Felix Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 21-12-2024
- Paid Up Capital ₹ 4.00 Cr
as on 21-12-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.00 Cr
as on 21-12-2024
- Revenue -96.93%
(FY 2020)
- Profit -25.20%
(FY 2020)
- Ebitda -60.21%
(FY 2020)
- Net Worth -63.07%
(FY 2020)
- Total Assets -5.22%
(FY 2020)
About Mickle Felix Pharmaceuticals
The Corporate was formerly known as Niramaya Pharmaceuticals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company has closed loans amounting to ₹4.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gurcharan Singh, Gajendra Shekhawat, and Mohinder Singh serve as directors at the Company.
- CIN/LLPIN
U24239DL2004PTC125291
- Company No.
125291
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Mickle Felix Pharmaceuticals Private Limited offer?
Mickle Felix Pharmaceuticals Private Limited offers a wide range of products and services, including Sexual Wellness Products, Erectile Dysfunction Medicine, Cardiovascular Drugs & Medication, Diabetes Medicine, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Mickle Felix Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gajendra Shekhawat  | Director | 25-Sep-2024 | Current |
Gurcharan Singh  | Director | 01-Jan-2014 | Current |
| Mohinder Singh | Director | 02-Apr-2021 | Current |
Financial Performance of Mickle Felix Pharmaceuticals.
Mickle Felix Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 96.93% decrease. The company also saw a substantial fall in profitability, with a 25.2% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mickle Felix Pharmaceuticals?
In 2020, Mickle Felix Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Guru Nanak Biotech Private LimitedActive 4 years 1 monthGurcharan Singh and Mohinder Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 15 Dec 2004 | ₹4.00 Cr | Satisfied |
How Many Employees Work at Mickle Felix Pharmaceuticals?
Mickle Felix Pharmaceuticals has a workforce of 11 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mickle Felix Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mickle Felix Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
